D-dimer Levels in Pregnant With COVID-19

Completed

• Conditions: COVID-19; D-dimer
• Interventions: Other: Blood D-dimer assay

• Registration Number: NCT04389554
• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary

D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-05
• Study Start: 2020-05-14
• Study First Submitted: 2020-05-14
• Study First Submitted QC: 2020-05-14
• Study First Posted: 2020-05-15
• Primary Completion: 2020-05-28
• Last Update Submitted: 2020-05-28
• Study Completion: 2020-05-29
• Last Update Posted: 2020-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• Pregnant women with COVID-19

Read More

Exclusion Criteria

• Having a chronic disease that raises D-dimer levels

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Control Group	Blood D-dimer assay	Healthy pregnant women
Study Group	Blood D-dimer assay	Pregnant women with COVID-19

Primary Outcome Measures

Name	Time	Method
Compare D-dimer values of COVID-19 patients and healthy pregnant women	one day

Trial Locations

Locations (1)

Kanuni Sultan Suleyman Training and Research Hospital; 🇹🇷 Istanbul, Turgut Ozal, Turkey